Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on May 2, 2025

ProHance Sparks Conversations on AI and Workforce Analytics at Shared Services & GCC Week India 2025
ProHance leads impactful dialogue on AI and workforce analytics at SSOW India 2025, showcasing insights to shape the future of shared services. BENGALURU, KARNATAKA, INDIA, May 2, 2025 /EINPresswire.com/ -- ProHance, a new-age workplace analytics and …

MindInventory Achieves Google Cloud Partner Status in Build Engagement Model to Accelerate Enterprise Innovation
Enhanced collaboration enables development of AI-powered industry solutions across healthcare, retail, and financial services sectors. STRONGSVILLE, OH, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- MindInventory, a leading digital solutions provider …

Secondary Ion Mass Spectrometer (SIMS) Market CAGR 6.02 % with Growth USD 281.94 Billion by 2033
PUNE, MAHARASHTRA, INDIA, May 2, 2025 /EINPresswire.com/ -- "Secondary Ion Mass Spectrometer (SIMS) Market" research report focus on overall information that can help to take decisions on current market situation. Global Secondary Ion Mass …

Gran Tierra Energy Announces Final Voting Results of its Annual Meeting of Stockholders
CALGARY, Alberta , May 02, 2025 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) today announced the voting results from the Company’s annual meeting of stockholders held on May 2, 2025. …

Conifex Announces First Quarter 2025 Results Conference Call
VANCOUVER, British Columbia, May 02, 2025 (GLOBE NEWSWIRE) -- Conifex Timber Inc. (“Conifex”) (TSX: CFF) announced today that it plans to release its first quarter 2025 results before market open on Monday, May 12, 2025. Conifex has scheduled a conference …

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIA FDA can grant final approval of YUTREPIA after blocking regulatory exclusivity expires on May 23, 2025 MORRISVILLE, N.C., May 02, 2025 (GLOBE …

Mount Logan Capital Inc. Schedules Release of First Quarter 2025 Results
TORONTO, May 02, 2025 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (CBOE: MLC) (“Mount Logan” or the “Company”) will release its financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 15, 2025. The Company will …

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Result of General Meeting
May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that …

Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
CHANDLER, Ariz., May 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, today announced that Rick Cassidy, Senior Vice President of Corporate …

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …

CloudLinux Names Aleksandra Mitroshkina as Vice President of Marketing for Imunify Security and CloudLinux OS Brands
CloudLinux strengthens its executive leadership team with the addition of experienced product marketing leader PALO ALTO, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- CloudLinux, the company behind secure and scalable operating systems for …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …

NurExone Expands European Engagement with Investor Events in Germany and Switzerland
TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …

Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call
GRAND CAYMAN, Cayman Islands, May 02, 2025 (GLOBE NEWSWIRE) -- Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (the "Company" or "Greenlight Re"), a multiline property and casualty insurer and reinsurer, today announced that it expects to release financial …

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …